A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis

• Selena Ferrian,

  Affiliation Division of Immunology, Institute of Infectious Disease and Molecular Medicine and National Health Laboratory Services, University of Cape Town, Cape Town, South Africa

  ⨯
• Claudia Manca,

  Affiliation Public Health Research Institute, Rutgers University, Newark, New Jersey, United States of America

  ⨯
• Sugnet Lubbe,

  Affiliation Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa

  ⨯
• Francesca Conradie,

  Affiliation Right to Care and the Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Nazir Ismail,

  Affiliation Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Gilla Kaplan,

  Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Clive M. Gray ,

  Contributed equally to this work with: Clive M. Gray, Dorothy Fallows

  Affiliation Division of Immunology, Institute of Infectious Disease and Molecular Medicine and National Health Laboratory Services, University of Cape Town, Cape Town, South Africa

  ⨯
• Dorothy Fallows

  Contributed equally to this work with: Clive M. Gray, Dorothy Fallows

  * E-mail: fallowda@njms.rutgers.edu

  Affiliation Public Health Research Institute, Rutgers University, Newark, New Jersey, United States of America

  http://orcid.org/0000-0003-0362-3345

  ⨯